Apoptotic effect of mtrix metalloproteinases 9 in the development of diabetic retinopathy

Yu Chen1, Wen Wang2, Fen Liu3

  • 1Department of Ophthamology, Second Xiangya Hospital Central South University Changsha 410013, Hunan, China ; Department of Ophthamology, Third Xiangya Hospital Central South University Changsha 410013, Hunan, China.

Abstract

Insights

Matrix metalloproteinase 9 (MMP9) is implicated in diabetic retinopathy (DR) development. Angiopoietin-2 (Ang2) regulates MMP9, which induces Müller cell apoptosis, contributing to DR progression.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Cell Biology

Background:

  • Diabetic retinopathy (DR) is a leading cause of vision loss.
  • The molecular mechanisms underlying DR pathogenesis require further elucidation.
  • Matrix metalloproteinase 9 (MMP9) is a potential factor in DR development.

Purpose of the Study:

  • To investigate the regulatory role of MMP9 in diabetic retinopathy (DR).
  • To explore the interaction between MMP9 and Angiopoietin-2 (Ang2) in retinal Müller cells.
  • To determine the effect of MMP9 on Müller cell apoptosis under high glucose conditions.

Main Methods:

  • Primary rat retinal Müller cells (RMCs) were transfected with MMP9 and Ang2 plasmids.
  • Cell viability and apoptosis were assessed using MTT assay and flow cytometry.
  • Western blot analysis was performed to evaluate apoptotic protein expression.

Main Results:

  • MMP9 overexpression increased RMC apoptosis, while MMP9 knockdown enhanced cell viability.
  • Ang2 significantly regulated MMP9 expression.
  • High glucose conditions upregulated MMP9 and apoptotic protein expression in RMCs.

Conclusions:

  • MMP9 plays a critical role in DR pathogenesis by inducing Müller cell apoptosis.
  • Ang2 is involved in the regulation of MMP9 in the context of DR.
  • Targeting MMP9 and associated apoptotic pathways may offer therapeutic strategies for DR.